RFA: Leukemia Exploration and Prevention Grant Program (LEAP)
The LEAP program (RUNX1 Research Program + American Cancer Society) funds investigator-initiated projects to discover and advance cancer interception or prevention strategies for individuals with RUNX1 familial platelet disorder (RUNX1-FPD). Funded work should focus on (1) mechanistic studies of leukemogenic steps affecting RUNX1-mutant HSPCs—including cell-autonomous and cell-nonautonomous fa…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Bone Marrow Failure, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
-
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
National Institutes of Health ▸ National Cancer Institute
-
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of Health ▸ National Cancer Institute
-
DoW Lung Cancer Translational Research Award
Dept. of the Army -- USAMRAA
-
Novel approaches to support therapeutic development in ultra-rare cancers
Food and Drug Administration
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers